S&P 500 Futures
(0.22%) 5 142.75 points
Dow Jones Futures
(0.18%) 38 512 points
Nasdaq Futures
(0.29%) 17 898 points
Oil
(-0.31%) $83.59
Gas
(1.98%) $1.961
Gold
(0.12%) $2 350.00
Silver
(0.48%) $27.67
Platinum
(1.01%) $931.45
USD/EUR
(-0.05%) $0.934
USD/NOK
(-0.14%) $11.01
USD/GBP
(-0.18%) $0.799
USD/RUB
(1.29%) $93.06

实时更新: Cassava Sciences Inc [SAVA]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
Upcoming Earnings Alert

Quarter results today
(tns 2024-04-29)

Expected move: +/- 8.13%

BUY
75.00%
return 5.74%
SELL
40.00%
return 3.32%
最后更新时间27 Apr 2024 @ 04:00

2.81% $ 22.34

购买 107293 min ago

@ $24.09

发出时间: 15 Feb 2024 @ 04:43


回报率: -7.26%


上一信号: Feb 14 - 04:46


上一信号: 出售


回报率: 0.75 %

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):
Profile picture for Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease...

Stats
今日成交量 1.07M
平均成交量 735 814
市值 965.65M
EPS $0 ( 2024-02-27 )
下一个收益日期 ( $-0.510 ) 2024-05-06
Last Dividend $5.25 ( 2012-12-13 )
Next Dividend $0 ( N/A )
P/E -9.63
ATR14 $0.0400 (0.18%)
Insider Trading
Date Person Action Amount type
2024-04-23 Barry Richard Buy 176 085 Common Stock
2024-01-03 Barry Richard Buy 117 390 Common Stock Warrant
2024-04-23 Barry Richard Sell 117 390 Common Stock Warrant
2024-04-18 Kupiec James William Buy 1 500 Common Stock
2024-01-03 Kupiec James William Buy 1 000 Common Stock Warrant
INSIDER POWER
68.79
Last 91 transactions
Buy: 2 039 016 | Sell: 658 296

音量 相关性

長: 0.01 (neutral)
短: -0.67 (moderate negative)
Signal:(52.294) Neutral

Cassava Sciences Inc 相关性

10 最正相关
CBIO0.848
GOOD0.844
ALXO0.828
ANGN0.828
CTBI0.825
MIRO0.819
RPRX0.813
CMPX0.813
DCRC0.808
BLUE0.806
10 最负相关
RNA-0.87
VKTX-0.844
BWMX-0.833
MTRY-0.832
DKDCA-0.826
CFFE-0.823
ROCL-0.821
LRMR-0.821
AMPH-0.814
EDTX-0.811

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Cassava Sciences Inc 相关性 - 货币/商品

The country flag -0.32
( neutral )
The country flag -0.35
( neutral )
The country flag 0.00
( neutral )
The country flag -0.15
( neutral )
The country flag 0.24
( neutral )
The country flag 0.68
( moderate )

Cassava Sciences Inc 财务报表

Annual 2023
营收: $0
毛利润: $-1.53M (0.00 %)
EPS: $-2.32
FY 2023
营收: $0
毛利润: $-1.53M (0.00 %)
EPS: $-2.32
FY 2022
营收: $-1 800.00
毛利润: $-1.30M (72 377.78 %)
EPS: $-1.800
FY 2021
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-0.820

Financial Reports:

No articles found.

Cassava Sciences Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Cassava Sciences Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $14.00 2010-12-13
Last Dividend $5.25 2012-12-13
Next Dividend $0 N/A
Payout Date 2012-12-24
Next Payout Date N/A
# dividends 2 --
Total Paid Out $19.25 --
Avg. Dividend % Per Year 0.00% --
Score 0.22 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-10-04)
$0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
0.22
Pay Frequency
Sporadic
Yearly Payout
Year Amount Yield
2010 $14.00 37.20%
2011 $0 0.00%
2012 $5.25 19.20%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-40.281.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.6241.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-0.5601.500-7.33-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM9.130.80010.008.00[1 - 3]
quickRatioTTM8.600.80010.008.00[0.8 - 2.5]
cashRatioTTM8.531.50010.0010.00[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM-1.9442.00-0.648-1.296[0 - 30]
freeCashFlowPerShareTTM-1.9542.00-0.977-1.954[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.3481.0007.537.53[0.2 - 0.8]
operatingProfitMarginTTM-45.291.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM0.01550.800-3.23-2.58[0.5 - 2]
Total Score-1.853

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-9.961.000-1.1080[1 - 100]
returnOnEquityTTM-0.5602.50-4.71-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM-1.9542.00-0.651-1.954[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-1.9442.00-0.648-1.296[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM1.7941.5001.3760[0.5 - 2]
operatingCashFlowSalesRatioTTM-34.931.000-10.000[0.1 - 0.5]
Total Score-2.16

Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。